Prevalence, Risk Factors and Potential Protective Strategies for Hypomagnesemia in Kidney Transplant Recipients
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26136528 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Cristina Riaza Ortiz und 10 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Department, San Carlos Clinical University Hospital, 28040 Madrid, Spain. Hauptthemen laut MEDLINE: Kidney Transplantation, Magnesium. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hypomagnesemia is the most common electrolyte disorder in kidney transplant recipients (KTR), yet its causes remain unclear. Few studies have explored its underlying factors. This study aimed to assess its prevalence and identify risk factors in KTR. We conducted a retrospective cross-sectional study in 489 outpatient KTR. Demographic, clinical, and laboratory data were collected. Univariate and multivariate logistic regression analyses were used to identify factors associated with hypomagnesemia (≤1.7 mg/dL). Hypomagnesemia was present in 50.7% of patients. Multivariate analysis identified tacrolimus [OR 2.91 (1.62–5.22)], thiazides [OR 2.23 (1.21–4.08)], cinacalcet [OR 2.31 (1.29–4.13)], serum phosphate < 3.7 mg/dL [1.99 (1.29–3.05)], serum calcium ≤ 10 mg/dL [1.99 (1.29–3.05)] and diabetes [1.94 (1.22–3.08)] as risk factors. Protective factors included SGLT2 inhibitors (SGLT2i) [OR 0.17 (0.10–0.27)] and mTOR inhibitors (mTORi) [OR 0.62 (0.38–0.98)]. Among hypomagnesemic patients, those receiving Mg2+ supplements had lower Mg2+ levels [1.54 (0.15) vs. 1.59 (0.13) mg/dL, p = 0.005] and higher fractional Mg2+ excretion [8.28 (4.48)% vs. 7.36 (4.19)%, p = 0.05]. Hypomagnesemia is highly prevalent in KTR. Tacrolimus, thiazides, and cinacalcet are key risk factors and, in some patients, risks and benefits of continuing these medications should be carefully weighed. In refractory cases, SGLT2i or mTORi may offer benefit.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nephrology Department, San Carlos Clinical University Hospital, 28040 Madrid, Spain.
- Biomedical Research Institute of San Carlos Clinical University Hospital, 28040 Madrid, Spain.
- Department of Medicine, Complutense University, 28040 Madrid, Spain.
- Clinical Analysis Department, San Carlos Clinical University Hospital, 28040 Madrid, Spain.
Zitieren
APA
Riaza Ortiz, C., Fernández Fernández, C., Pujol Pujol, M., Muñiz Rincón, M., Aiffil Meneses, A. S., Pérez Flores, I. M., Calvo Romero, N., Moreno de la Higuera, M. Á., Rodríguez Cubillo, B., Ramos Corral, R., & Sánchez Fructuoso, A. I. (2025). Prevalence, Risk Factors and Potential Protective Strategies for Hypomagnesemia in Kidney Transplant Recipients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136528
Vancouver
Riaza Ortiz C, Fernández Fernández C, Pujol Pujol M, Muñiz Rincón M, Aiffil Meneses AS, Pérez Flores IM, et al. Prevalence, Risk Factors and Potential Protective Strategies for Hypomagnesemia in Kidney Transplant Recipients. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136528
BibTeX
@article{RiazaOrtiz2025,
author = {Riaza Ortiz, Cristina and Fernández Fernández, Carlos and Pujol Pujol, Marina and Muñiz Rincón, María and Aiffil Meneses, Arianne Sofía and Pérez Flores, Isabel María and Calvo Romero, Natividad and Moreno de la Higuera, María Ángeles and Rodríguez Cubillo, Beatriz and Ramos Corral, Raquel and Sánchez Fructuoso, Ana Isabel},
title = {Prevalence, Risk Factors and Potential Protective Strategies for Hypomagnesemia in Kidney Transplant Recipients},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26136528}
}
EUVIMED